Gleason Score Predicts Androgen Independent Progression after Androgen Deprivation Therapy

Author： Benaim E.A.   Pace C.M.   Roehrborn C.G.  

Publisher： Elsevier

ISSN： 0302-2838

Source： European Urology, Vol.42, Iss.1, 2002-07, pp. : 12-17

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Upregulation of prostate-specific membrane antigen after androgen-deprivation therapy

By Wright G.L.   Grob M.   Haley C.   Grossman K.   Newhall K.   Petrylak D.   Troyer J.   Konchuba A.   Schellhammer P.F.   Moriarty R.  

Urology, Vol. 48, Iss. 2, 1996-08 ,pp. : 326-334

Elsevier

Access to resources Recommend Favorite

Androgen independent progression in prostate cancer: Risk factors

By Auzanneau C.   Irani J.   Dahmani L.   Ouaki F.   Pires C.   Dore B.  

European Urology Supplements, Vol. 2, Iss. 1, 2003-02 ,pp. : 26-26

Elsevier

Access to resources Recommend Favorite

Newer approaches to androgen deprivation therapy in prostate cancer

By Pitts W.R.  

Urology, Vol. 61, Iss. 4, 2003-04 ,pp. : 882-882

Elsevier

Access to resources Recommend Favorite

Increase of bone alkaline phosphatase after androgen deprivation therapy in patients with prostate cancer

By Morote J.   M'Hammed Y.I.D.   Martinez E.   Esquena S.   Lorente J.A.   Gelabert A.  

Urology, Vol. 59, Iss. 2, 2002-02 ,pp. : 277-280

Elsevier

Access to resources Recommend Favorite

Use of additional treatment for prostate cancer after radical prostatectomy, radiation therapy, androgen deprivation, or watchful waiting

By Berge Viktor   Thompson Trevor   Blackman Donald  

Scandinavian Journal of Urology and Nephrology, Vol. 41, Iss. 3, 2007-01 ,pp. : 198-203

Informa Healthcare

Access to resources Recommend Favorite